文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

聚乙二醇化 DDA:TDB 脂质体佐剂可降低疫苗储库效应并改变 Th1/Th2 免疫应答。

Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses.

机构信息

School of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK.

出版信息

J Control Release. 2012 Feb 28;158(1):72-7. doi: 10.1016/j.jconrel.2011.10.012. Epub 2011 Oct 18.


DOI:10.1016/j.jconrel.2011.10.012
PMID:22032883
Abstract

The adjuvant efficacy of cationic liposomes composed of dimethyldioctadecylammonium bromide and trehalose dibehenate (DDA:TDB) is well established. Whilst the mechanism behind its immunostimulatory action is not fully understood, the ability of the formulation to promote a 'depot effect' is a consideration. The depot effect has been suggested to be primarily due to their cationic nature which results in electrostatic adsorption of the antigen and aggregation of the vesicles at the site of injection. The aim of the study was to further test this hypothesis by investigating whether sterically stabilising DDA:TDB with polyethylene glycol (PEG) reduces aggregation, and subsequently influences the formation of a depot at the site of injection. Results reported demonstrate that high (25%) levels of PEG was able to significantly inhibit the formation of a liposome depot and also severely limit the retention of antigen at the site, resulting in a faster drainage of the liposomes from the site of injection. This change in biodistribution profile was reflected in the immunisation response, where lower levels of IgG2b antibody and IFN-γ and higher level of IL-5 cytokine were found. Furthermore entrapping antigen within DDA:TDB liposomes did not improve antigen retention at the injection site compared surface adsorbed antigen.

摘要

二油酰基磷脂酰乙醇胺(DOPE)-胆固醇(Chol)脂质体作为基因载体的研究进展

相似文献

[1]
Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses.

J Control Release. 2011-10-18

[2]
Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response.

J Control Release. 2012-7-16

[3]
Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen.

J Control Release. 2009-10-26

[4]
The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production.

J Control Release. 2011-5-27

[5]
Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01.

J Control Release. 2018-10-3

[6]
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog.

J Control Release. 2012-3-27

[7]
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.

Biochim Biophys Acta. 2005-12-10

[8]
Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants.

J Pharm Pharmacol. 2013-11-19

[9]
A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice.

J Pharm Pharmacol. 2006-6

[10]
Effect of incorporating cholesterol into DDA:TDB liposomal adjuvants on bilayer properties, biodistribution, and immune responses.

Mol Pharm. 2014-1-6

引用本文的文献

[1]
Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus.

Diseases. 2023-12-10

[2]
Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity.

Biomater Sci. 2022-10-25

[3]
Vesicular and Planar Membranes of Archaea Lipids: Unusual Physical Properties and Biomedical Applications.

Int J Mol Sci. 2022-7-9

[4]
Development of a rapid in vitro pre-screen for distinguishing effective liposome-adjuvant delivery systems.

Sci Rep. 2022-7-20

[5]
Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines.

Pharmaceutics. 2021-6-24

[6]
Cationic Nanoparticle-Based Cancer Vaccines.

Pharmaceutics. 2021-4-21

[7]
The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration.

Vaccines (Basel). 2021-2-6

[8]
Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines.

Pharmaceutics. 2020-12-30

[9]
Covering Aluminum Oxide Nanoparticles with Biocompatible Materials to Efficiently Deliver Subunit Vaccines.

Vaccines (Basel). 2019-6-17

[10]
Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease.

J Immunotoxicol. 2019-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索